Search

everythinglearnresearchcommunity

for

Search:↓

AAG causes hair loss in many people, with limited treatments like finasteride, minoxidil, light therapy, and hair transplants.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Hair loss can cause emotional and social issues, and various treatments, including medication, surgery, and psychological support, are needed.

The book provides a detailed guide on managing Polycystic Ovary Syndrome and is useful for physicians.

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.

Women generally want more hair volume, which becomes a concern around menopause due to hair loss.

Hair loss treatments show limited improvement, sunscreen thickness affects vitamin D production, and the effectiveness of IVIg for toxic epidermal necrolysis is uncertain.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Nanoemulgels could effectively treat skin diseases and may replace or complement current therapies.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Menopause can cause hair thinning and texture changes due to hormonal and metabolic shifts.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Use minoxidil for hair loss treatment; assess results after 6 months.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Oral finasteride works better than topical minoxidil for hair growth, both are safe.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.